GlucoTrack, Inc. - Common Stock (GCTK)
7.7800
-2.8100 (-26.53%)
NASDAQ · Last Trade: Sep 15th, 9:56 PM EDT
Detailed Quote
Previous Close | 10.59 |
---|---|
Open | 8.690 |
Bid | 8.020 |
Ask | 8.060 |
Day's Range | 7.200 - 8.880 |
52 Week Range | 4.220 - 3,576.00 |
Volume | 1,076,285 |
Market Cap | 7.00M |
PE Ratio (TTM) | 0.0986 |
EPS (TTM) | 78.9 |
Dividend & Yield | N/A (N/A) |
1 Month Average Volume | 4,072,847 |
Chart
About GlucoTrack, Inc. - Common Stock (GCTK)
GlucoTrack, Inc. is a healthcare technology company focused on the development of innovative non-invasive glucose monitoring solutions for individuals with diabetes. The company leverages advanced sensing technologies to create devices that enable users to track their blood glucose levels without the need for traditional fingerstick methods. GlucoTrack aims to improve the quality of life for diabetic patients by providing them with more convenient and accessible ways to manage their condition, while also enabling healthcare providers to better monitor patient health. Through its commitment to research and development, GlucoTrack seeks to contribute to more effective diabetes management and enhance overall patient outcomes. Read More
News & Press Releases
Curious about what's happening in today's session? Check out the latest stock movements and price changes.
Via Chartmill · September 15, 2025
Via Benzinga · September 15, 2025
Looking for insights into the US markets in the middle of the day on Monday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.
Via Chartmill · September 15, 2025
Glucotrack Stock Just Rose Over 123% Today: Here’s An Important Updatestocktwits.com
Via Stocktwits · September 12, 2025
In today's session, there are notable price gaps in the US markets on Monday. Take a closer look at the stocks that are gap up and gap down.
Via Chartmill · September 15, 2025
Before the opening bell on Monday, let's take a glimpse of the US markets and explore the top gainers and losers in today's pre-market session.
Via Chartmill · September 15, 2025
Via Benzinga · September 15, 2025
Via Benzinga · September 15, 2025
Via Benzinga · September 15, 2025
Via Benzinga · September 12, 2025
Let's have a look at what is happening on the US markets after the closing bell on Friday. Below you can find the top gainers and losers in today's after hours session.
Via Chartmill · September 12, 2025
Wondering how the US markets performed one hour before the close of the markets on Friday? Discover the movers and shakers of today's session in our comprehensive analysis.
Via Chartmill · September 12, 2025
Via Benzinga · September 12, 2025
Via Benzinga · September 12, 2025
Curious to know what's happening on the US markets in the middle of the day on Friday? Join us as we explore the top gainers and losers in today's session.
Via Chartmill · September 12, 2025
Let's delve into the US markets on Friday and uncover the stocks that are experiencing notable gaps in today's session. Below, you'll find the gap up and gap down stocks.
Via Chartmill · September 12, 2025
The US market session of Friday has yet to be opened, let's have a look at the top gainers and losers in the pre-market session today.
Via Chartmill · September 12, 2025
Via Benzinga · September 12, 2025
RUTHERFORD, N.J., Sept. 11, 2025 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK) (“Glucotrack” or the “Company”), a medical technology company focused on the design, development, and commercialization of novel technologies for people with diabetes, today announced that management will present and participate in one-on-one meetings with investors at the Q3 Virtual Investor Summit, being held on September 16-17, 2025.
By Glucotrack, Inc. · Via GlobeNewswire · September 11, 2025
The session on Tuesday is off to an intriguing start with several stocks showing significant price gaps. Let's examine the gap up and gap down stocks in today's session.
Via Chartmill · September 2, 2025
As we await the opening of the US market on Tuesday, let's delve into the pre-market session and discover the top gainers and losers shaping the early market sentiment.
Via Chartmill · September 2, 2025
Via Benzinga · September 2, 2025
Via Benzinga · September 2, 2025
Experienced cardiac electrophysiologist joins Glucotrack’s growing clinical advisory team as the Company advances its long-term CBGM through critical clinical milestones
By Glucotrack, Inc. · Via GlobeNewswire · August 6, 2025